Phaseline

Companies › Candel Therapeutics

Candel Therapeutics: clinical trials, targets and expected readouts

1 active drug program in 5 registered trials: 3 Phase 2, 2 Phase 3; Oncology; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Aglatimagene Besadenovec–Phase 3Prostate Cancer; Non-squamous, Non-Small Cell Lung Cancer; Prostate Cancer Patients Treated by Radiotherapy; Non Small Cell Lung CancerDec 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT02768363Aglatimagene BesadenovecPhase 2Prostate CancerOncologyDec 2026
NCT07332000Aglatimagene BesadenovecPhase 2Prostate Cancer Patients Treated by RadiotherapyOncologyFeb 2027
NCT04495153Aglatimagene BesadenovecPhase 2Non Small Cell Lung CancerOncologyDec 2027
NCT01436968Aglatimagene BesadenovecPhase 3Prostate CancerOncologyDec 2030
NCT07660094Aglatimagene BesadenovecPhase 3Non-squamous, Non-Small Cell Lung CancerOncologyOct 2031

From the company's SEC filings

Cash of $202m on 2026-06-30; operating cash outflow about $71m a year; runway about 34 months at that burn, to Apr 2029; 3 of 5 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Agreements filed with the SEC (item 1.01), last two years

Specialist investors

Held by 2 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Immutep S.A.S. ADC Therapeutics Actinium Pharmaceuticals Maia Biotechnology K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.